Protective role of murine β-defensins 3 and 4 and cathelin-related antimicrobial peptide in fusarium solani keratitis

Infection and Immunity

Volumn 81, Issue 8, 2013, Pages 2669-2677

  Kolar, Satya Sree N ^a   Baidouri, Hasna ^a   Hanlon, Samuel ^a   McDermott, Alison M ^a  

^a UNIVERSITY OF HOUSTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA DEFENSIN 3; BETA DEFENSIN 4; CATHELICIDIN; CATHELIN; CATHELIN RELATED ANTIMICROBIAL PEPTIDE; MYELOPEROXIDASE; POLYPEPTIDE ANTIBIOTIC AGENT; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORNEA DISEASE; DISEASE COURSE; DISEASE SEVERITY; FUSARIUM SOLANI; INFLAMMATION; KERATOMYCOSIS; KNOCKOUT MOUSE; MOUSE; NEUTROPHIL; NONHUMAN; PATHOGEN CLEARANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SLIT LAMP;

ANIMALS; BETA-DEFENSINS; CATHELICIDINS; DISEASE MODELS, ANIMAL; FEMALE; FUSARIOSIS; IMMUNOHISTOCHEMISTRY; KERATITIS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84880690464     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00179-13     Document Type: Article

References (39)

1. Alfonso EC, Galor A, Miller D. 2010. Fungal keratitis in cornea, p 1009-1022. In Krachmer JH, Mannis MJ, Holland EH (ed), Cornea: fundamentals in cornea and external disease. Elsevier Mosby, Maryland Heights, MD.
2. Gopinathan U, Sharma S, Garg P, Rao GN. 2009. Review of epidemio-logical features, microbiological diagnosis and treatment outcome of mi-crobial keratitis: experience of over a decade. Indian J. Ophthalmol. 57: 273-279.
3. Sirikul T, Prabriputaloong T, Smathivat A, Chuck RS, Vongthongsri A. 2008. Predisposing factors and etiologic diagnosis of ulcerative keratitis. Cornea 27:283-287.
4. Wang L, Sun S, Jing Y, Han L, Zhang H, Yue J. 2009. Spectrum of fungal keratitis in central China. Clin. Exp. Ophthalmol. 37:763-771.
5. Gaujoux T, Chatel MA, Chaumeil C, Laroche L, Borderie VM. 2008. Outbreak of contact lens-related Fusarium keratitis in France. Cornea 27:1018-1021.
6. Patel A, Hammersmith K. 2008. Contact lens-related microbial keratitis: recent outbreaks. Curr. Opin. Ophthalmol. 19:302-306.
7. Thomas PA. 2003. Fungal infections of the cornea. Eye 17:852-862.
8. Zhong WX, Sun SY, Zhao J, Shi WY, Xie LX. 2007. Retrospective study of suppurative keratitisin 1054 patients. Zhonghua YanKeZaZhi 43:245-250.
9. Karthikeyan RS, Leal SM, Jr, Prajna NV, Dharmalingam K, Geiser DM, Pearlman E, Lalitha P. 2011. Expression of innate and adaptive immune mediators in human corneal tissue infected with Aspergillus or Fusarium. J. Infect. Dis. 204:942-950.
10. Leal SM, Jr, Pearlman E. 2012. The role of cytokines and pathogen recognition molecules in fungal keratitis-insights from human disease and animal models. Cytokine 58:107-111.
11. Jurkunas UV, Langston DP, Colby K. 2007. Use of voriconazole in the treatment of fungal keratitis. Int. Ophthalmol. Clin. 47:47-59.
12. Edelstein SL, Akduman L, Durham BH, Fothergill AW, Hsu HY. 2012. Resistant Fusarium keratitis progressing to endophthalmitis. Eye Contact Lens 38:331-335.
13. McDermott AM. 2009. Antimicrobial peptides, p 357-401. In Howl J, Jones S (ed). Bioactive peptides. CRC Press, London, United Kingdom.
14. Steinstraesser L, Kraneburg U, Jacobsen F, Al-Benna S. 2011. Host defense peptides and their antimicrobial-immunomodulatory duality. Immunobiology 216:322-333.
15. Aerts AM, François IE, Cammue BP, Thevissen K. 2008. The mode of antifungal action of plant, insect and human defensins. Cell. Mol. Life Sci. 65:2069-2079.
16. Vylkova S, Nayyar N, Li W, Edgerton M. 2007. Human beta-defensins kill Candida albicans in an energy-dependent and salt-sensitive manner without causing membrane disruption. Antimicrob. Agents Chemother. 51:154-161.
17. den Hertog AL, van Marle J, van Veen HA, Van't Hof W, Bolscher JG, Veerman EC, Nieuw Amerongen AV. 2005. Candidacidal effects of two antimicrobial peptides: histatin 5 causes small membrane defects, but LL-37 causes massive disruption of the cell membrane. Biochem. J. 388: 689-695.
18. van der Weerden NL, Hancock RE, Anderson MA. 2010. Permeabiliza-tion of fungal hyphae by the plant defensin NaD1 occurs through a cell wall-dependent process. J. Biol. Chem. 285:37513-37520.
19. López-García B, Lee PH, Yamasaki K, Gallo RL. 2005. Antifungal activity of cathelicidins and their potential role in Candida albicans skin infection. J. Investig. Dermatol. 125:108-115.
20. De Yang Chen Q, Schmidt AP, Anderson GM, Wang JM, Wooters J, Oppenheim JJ, Chertov O. 2000. LL-37, the neutrophil granule-and epithelial cell derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutro-phils, monocytes, and T cells. J. Exp. Med. 192:1069-1074.
21. Yang D, Chertov O, Oppenheim JJ. 2001. Participation of mammalian defensins and cathelicidins in anti-microbial immunity: receptors and activities of human defensins and cathelicidin (LL-37). J. Leukoc. Biol. 69: 691-697.
22. McDermott AM. 2009. The role of antimicrobial peptides at the ocular surface. Ophthalmic Res. 41:60-75.
23. Huang LC, Reins RY, Gallo RL, McDermott AM. 2007. Cathelicidin-deficient (Cnlp) mice show increased susceptibility to Pseudomonas aeruginosa keratitis. Investig. Ophthalmol. Vis. Sci. 48:4498-4508.
24. Wu M, McClellan SA, Barrett RP, Zhang Y, Hazlett LD. 2009. Beta-defensins 2 and 3 together promote resistance to Pseudomonas aeruginosa keratitis. J. Immunol. 183:8054-8060.
25. Wu M, McClellan SA, Barrett RP, Hazlett LD. 2009. β-Defensin-2 promotes resistance against infection with P. aeruginosa. J. Immunol. 182: 1609-1616.
26. Kolar SS, McDermott AM. 2011. Role of host-defence peptides in eye diseases. Cell. Mol. Life Sci. 68:2201-2213.
27. Yuan X, Hua X, Wilhelmus KR. 2010. The corneal expression of antimicrobial peptides during experimental fungal keratitis. Curr. Eye Res. 35:872-879.
28. Gao N, Kumar A, Guo H, Wu X, Wheater M, Yu F-S. 2011. Topical flagellin mediated innate defence against Candida albicans keratitis. Investig. Ophthalmol. Vis. Sci. 52:3074-3082.
29. Hume EB, Flanagan J, Masoudi S, Zhu H, Cole N, Willcox MD. 2009. Soft contact lens disinfection solution efficacy: clinical Fusarium isolates vsATCC 36031. Optom. Vis. Sci. 86:415-419.
30. Wu TG, Keasler W, Mitchell BM, Wilhelmus KR. 2004. Immunosup-pression affects the severity of experimental Fusarium solani keratitis. J. Infect. Dis. 190:192-198.
31. Nizet V, Ohtake T, Lauth X, Trowbridge J, Rudisill J, Dorschner RA, Pestonjamasp V, Piraino J, Huttner K, Gallo RL. 2001. Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 414:454-457.
32. Sun Y, Chandra J, Mukherjee P, Szczotka-Flynn L, Ghannoum MA, Pearlman E. 2010. A murine model of contact lens-associated Fusarium keratitis. Investig. Ophthalmol. Vis. Sci. 51:1511-1516.
33. Cole N, Hume E, Khan S, Krockenberger M, Thakur A, Husband AJ, Willcox MD. 2005. Interleukin-4 is not critical to pathogenesis in a mouse model of Pseudomonas aeruginosa corneal infection. Curr. Eye Res. 30: 535-542.
34. Sun Y, Pearlman E. 2009. Inhibition of corneal inflammation by the TLR4 antagonist Eritoran tetrasodium (E5564). Investig. Ophthalmol. Vis. Sci. 50:1247-1254.
35. Wu TG, Wilhelmus KR, Mitchell BM. 2003. Experimental keratomyco-sis in a mouse model. Investig. Ophthalmol. Vis. Sci. 44:210-216.
36. Tarabishy AB, Aldabagh B, Sun Y, Imamura Y, Mukherjee PK, Lass JH, Ghannoum MA, Pearlman E. 2008. MyD88 regulation of Fusarium keratitis is dependent on TLR4 and IL-1R1 but not TLR2. J. Immunol. 181: 593-600.
37. Shin SY, Kang SW, Lee DG, Eom SH, Song WK, Kim JI. 2000. CRAMP analogues having potent antibiotic activity against bacterial, fungal, and tumor cells without hemolytic activity. Biochem. Biophys. Res. Commun. 275:904-909.
38. Jiang Y, Yi X, Li M, Wang T, Qi T, She X. 2012. Antimicrobial activities of recombinant mouse [3-defensin 3 and its synergy with antibiotics. J. Mater. Sci. Mater. Med. 23:1723-1728.
39. Kurosaka K, Chen Q, Yarovinsky F, Oppenheim JJ, Yang D. 2005. Mouse cathelin-related antimicrobial peptide chemoattracts leukocytes using formyl peptide receptor-like 1/mouse formyl peptide receptor-like 2 as the receptor and acts as an immune adjuvant. J. Immunol. 174:6257-6265.